| Product Name | Deracoxib-d4 |
| Product Code | DA-D074-03 |
| Chemical name | Deracoxib-d4 |
| Synonyms | 4-[3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl]benzenesulfonamide-d4; Deram-d4; Deramaxx-d4; SC 046-d4; SC 46-d4; SC 59046-d4; 4-[5-(3-Fluoro-4-methoxyphenyl)-3-(difluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide-d4; |
| Impurity | NA |
| CAS Number | 1794780-24-7 |
| Alternate CAS # | NA |
| Molecular form | C17H10D4F3N3O3S |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 401.40 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | aromatics,heterocycles,pharmaceutical standards,intermediates,fine chemicals,sulphur and selenium compounds,stable isotopes |
| Boiling Point | NA |
| Applications | Labelled Deracoxib, a non-steroidal anti-inflammatory drug (NSAID) of the coxib class. Deracoxin is a selective cyclooxygenase-2 (COX-2) inhibitor used in the treatment of osteoarthritis in dogs. At low doses, adminsitartion of Deracoxin showed no factors associated with gastrointestinal tract perforation. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
